Formulary
|
Dermatology prescribing may require use of expensive unlicensed Specials Recommended by the British Association of Dermatologists for Skin Disease |
|
Several medicines in the skin chapter are available for purchase over the counter and may be appropriate for self care. Please consult the local OTC policy for more details. LSCMMG: Over The Counter (OTC) Items That Should Not Be Routinely Prescribed In Primary Care Policy |
MHRA: Risk of severe and fatal burns with paraffin-containing and paraffin-free emollients
Advise patients who use these products not to smoke or go near naked flames, and warn about the easy ignition of clothing, bedding, dressings, and other fabric that have dried residue of an emollient product on them.
Emollient bath and shower preparations are no longer recommended. Most emollients can be used as a soap substitute.
| Epimax® |
|
Formulary
|
Cream Do not prescribe Epimax® ointment for use on the face. |
 MHRA: Epimax Ointment and Epimax Paraffin-Free Ointment: reports of ocular surface toxicity and ocular chemical injury |
|
Links
Lancashire and South Cumbria Infant Feeding Network - Diagnosis and Management of Milk Allergy and Intolerance Guideline- LSCMMG: Inflammatory Bowel Disease: High Cost Drugs Commissioning Pathway
- LSCMMG: Primary Care Constipation Guidelines
- MHRA Drug Safety Update April 2016: Paraffin-based skin emollients on dressings or clothing: fire risk
- MHRA Drug Safety Update Aug 2020: Emollients and risk of severe and fatal burns: new resources available
- MHRA Drug Safety Update Dec 2018: Emollients: new information about risk of severe and fatal burns with paraffin-containing and paraffin-free emollients
- MHRA: Antiepileptic drugs in pregnancy: updated advice following comprehensive safety review
- MHRA: Epimax Ointment and Epimax Paraffin-Free Ointment: reports of ocular surface toxicity and ocular chemical injury
- NICE CG147: Diverticular disease: diagnosis and management
- NICE CG184 Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management
- NICE CG61: Irritable bowel syndrome in adults: diagnosis and management
- NICE NG1: Gastro-oesophageal reflux disease: recognition, diagnosis and management in children and young people